What is Modular Medical's market cap?

Modular Medical (MODD) has a market capitalization of $12.5M and trades on NASDAQ.

Who are Modular Medical's competitors?

Modular Medical's key competitors include Tandem Diabetes Care, Inc., Insulet Corporation, MannKind Corporation, and others. These companies compete in similar markets and product categories.

Who does Modular Medical partner with?

Modular Medical's notable partners include Phillips Medisize, ISA, Seagrove Partners, LLC, and others.

What subsidiaries does Modular Medical have?

Modular Medical's subsidiaries include Quasuras, Inc..

Where is Modular Medical headquartered?

Modular Medical is headquartered in United States of America and employs approximately 40 people. It has been publicly traded since 2022.

Modular Medical

MODD

Modular Medical is a medical device company focused on the design and commercialization of innovative insulin pumps for the diabetes marketplace.

Market cap

$12.5M-67.1%

Table of contents

Earnings

Q4 2025 report

February 17, 2026

EPS-$3.30Miss by $0.30

Read the full report

Next report

Sep 2, 2026 (in a month)

Competitors

By market cap

Medtronic$107.81B-8.5%

Insulet$11.4B-44.4%

Mannkind$1.2B+1.4%

Tandem Diabetes Care$1.2B+4.9%

Beta Bionics, Inc.$712.5M+17.5%

Embecta Corp.$203.8M-69.2%

Oramed Pharmaceuticals$170.3M+88.6%

Modular Medical$12.5M-67.1%

By revenue growth

Beta Bionics, Inc.+57.9%

Insulet+31.9%

Mannkind+21.2%

Medtronic+8.4%

Tandem Diabetes Care+4.5%

Embecta Corp.-3.4%

By net margin

Medtronic13.2%-0.7pp

Embecta Corp.10.73%+5.8pp

Insulet10.44%-7.9pp

Mannkind9.32%-7.8pp

Tandem Diabetes Care-9.2%+9.5pp

Beta Bionics, Inc.-60.27%+41.4pp

Profile

Modular Medical is a medical device company focused on the design and commercialization of innovative insulin pumps for the diabetes marketplace. The company aims to expand the wearable insulin delivery market by simplifying the user experience and reducing costs to reach the mass market of both Type 1 and Type 2 diabetes patients. Its core value proposition centers on a proprietary two-part patch pump design that balances ease of use with high-precision delivery.

Competitive position

An emerging challenger focusing on the underserved 'mass market' by offering lower-cost, simplified alternatives to complex legacy insulin pumps.

GeographiesUnited States, Europe

Customer segmentsPatients, Healthcare Providers, Pharmacy Benefit Managers

Business modelManufacturing, Direct-to-Consumer, B2B

SuppliersConsumer electronics component suppliers, Contract manufacturing organizations, Infusion set third-party manufacturers

CustomersDiabetes educator practices, Primary care physicians, Medical device distributors, Pharmacy Benefit Managers (PBMs)

CountryUnited States of America

Listed2022

Employees40.0

CEOJames E. Besser

SectorHealthcare

IndustryMedical - Devices

Websitemodular-medical.com

FilingsSEC EDGAR

Questions, answered.

What is Modular Medical's market cap?: Modular Medical (MODD) has a market capitalization of $12.5M and trades on NASDAQ.
Who are Modular Medical's competitors?: Modular Medical's key competitors include Tandem Diabetes Care, Inc., Insulet Corporation, MannKind Corporation, and others. These companies compete in similar markets and product categories.
Who does Modular Medical partner with?: Modular Medical's notable partners include Phillips Medisize, ISA, Seagrove Partners, LLC, and others.
What subsidiaries does Modular Medical have?: Modular Medical's subsidiaries include Quasuras, Inc..
Where is Modular Medical headquartered?: Modular Medical is headquartered in United States of America and employs approximately 40 people. It has been publicly traded since 2022.